feedback

Course Director

Nicolas Roche, MD, PhD
Nicolas Roche, MD, PhD

Paris Descartes University
Cochin Hospital
Paris, France

Faculty

Ian Pavord
Ian Pavord, DM, FMedSci

University of Oxford
Oxford, United Kingdom

Accredited by

Oakstone Publishing, LLC

View Activity Materials

Activity Details

Credit Types:CME
Credit Amount:0.5 Credits
Release Date:2017-Aug-18
Expiration Date:2018-Aug-17
Estimated Time for Completion:30 minutes
Registration Required:No
Cost:Free of Charge

Funding Disclosure

This activity is supported by an educational grant from AstraZeneca.

Activity Description and Educational Objectives

In this activity, experts in severe asthma discuss key clinical data associated with new and emerging biologic therapies for severe asthma, and the relevance of these data for current practice.

Upon completion of this activity, participants should be better able to:

  • Discuss clinical data evaluating the efficacy and safety of new and emerging monoclonal antibodies for the management of uncontrolled severe asthma
  • Identify opportunities to individualise treatment plans for patients with severe Th2-mediated asthma, based on these data

Target Audience

This activity has been designed to meet the educational needs of pulmonologists, allergists, and other clinicians involved in the management of severe asthma.

Faculty Disclosure Statement / Conflict of Interest Policy

Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors, and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing’s planners, medical reviewers, and editorial staff disclose no relevant financial relationships with commercial interests.

Course Director

Nicolas Roche, MD, PhD
Professor of Respiratory Medicine, Paris Descartes University
Senior Consultant, Respiratory and Intensive Care Medicine, Cochin Hospital
Paris, France

Nicolas Roche, MD, PhD, has a financial interest/relationship or affiliation in the form of:
Consultant for AstraZeneca Plc; Boehringer Ingelheim GmbH; Chiesi Farmaceutici S.p.A.; GlaxoSmithKline Plc; Mundipharma Research GmbH & Co. KG; Novartis Pharmaceuticals; and Teva Pharmaceutical Industries Ltd.
Grant/Research Support from Boehringer Ingelheim GmbH; Novartis Pharmaceuticals; and Pfizer Inc.
Speakers Bureau participant with Boehringer Ingelheim GmbH; Chiesi Farmaceutici S.p.A.; GlaxoSmithKline Plc; and Novartis Pharmaceuticals.
Honoraria from 3M; AstraZeneca Plc; Boehringer Ingelheim GmbH; Chiesi Farmaceutici S.p.A.; GlaxoSmithKline Plc; Mundipharma Research GmbH & Co. KG; Novartis Pharmaceuticals; Pfizer Inc; Sandoz Ltd; sanofi-aventis U.S. LLC; Teva Pharmaceutical Industries Ltd; and Zambon S.p.A.
Advisory Board for 3M; AstraZeneca Plc; Boehringer Ingelheim GmbH; Chiesi Farmaceutici S.p.A.; GlaxoSmithKline Plc; Novartis Pharmaceuticals; and Teva Pharmaceutical Industries Ltd.

Faculty

Ian Pavord, DM, FMedSci
Professor of Respiratory Medicine
University of Oxford
Oxford, United Kingdom

Ian Pavord, DM, FMedSci, has a financial interest/relationship or affiliation in the form of:
Speakers Bureau participant with Aerocrine AB; Almirall Hermal GmbH; Astra Zeneca Plc; Boehringer Ingelheim GmbH; GlaxoSmithKline Plc; Novartis Pharmaceuticals UK Limited; and Teva Pharmaceutical Industries Ltd.
Honoraria from Aerocrine AB; Almirall Hermal GmbH; Astra Zeneca Plc; Boehringer Ingelheim GmbH; Dey Pharma, L.P.; Genentech, Inc; GlaxoSmithKline Plc; Merck & Co., Inc; MSD; Napp Pharmaceuticals Group Ltd; Novartis Pharmaceuticals UK Limited; Regeneron Pharmaceuticals, Inc; Respivert, Ltd.; Schering-Plough Corporation; and Teva Pharmaceutical Industries Ltd.
Advisory Board for Almirall Hermal GmbH; Astra Zeneca Plc; Boehringer Ingelheim GmbH; Dey Pharma, L.P.; Genentech, Inc; GlaxoSmithKline Plc; Merck & Co., Inc; MSD; Napp Pharmaceuticals Group Ltd; Novartis Pharmaceuticals UK Limited; Regeneron Pharmaceuticals, Inc; Respivert, Ltd.; Schering-Plough Corporation; and Teva Pharmaceutical Industries Ltd.

CME Reviewer

W. Murray Yarbrough, MD
Oakstone Publishing, LLC
Birmingham, Alabama, USA

W. Murray Yarbrough, MD, has a financial interest/relationship or affiliation in the form of:
Shareholder in GILD.

PeerVoice Medical Director

Christy Rohani, PhD, has no financial interests/relationships or affiliations in relation to this activity.

Disclosure of Unlabelled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labelled for use in certain jurisdictions. Faculty members have been advised to disclose to the audience any reference to an unlabelled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our materials. No responsibility is taken for errors or omissions in our materials.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing, LLC and PeerVoice. Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Oakstone Publishing, LLC designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit™ into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).

This CME activity is jointly provided by Oakstone Publishing, LLC and PeerVoice.

Requirements for Successful Completion

To receive credit, participants must complete the activity, the post-test, and the evaluation form prior to the expiration date noted below. There are no pre-requisites and there is no fee to participate in this activity or to receive credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form. Consult your professional licensing board for information about your eligibility to claim credit for participation in this educational activity. A minimum performance level of 70% is needed.

Media: Enduring Material
Release and Expiration Dates: August 18, 2017 - August 17, 2018
Time to Complete: 30 minutes

Disclaimer

The participants of this educational activity have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerVoice or any of its supporters.

For technical assistance, please contact us.

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.